Corticosteroid Nasal Irrigation as Early Treatment of Olfactory Dysfunction in COVID-19: A prospective randomized controlled trial : Corticosteroid Nasal Irrigation as Early Treatment of Olfactory Dysfunction in COVID-19: A prospective randomized controlled trial

Media Type:

Clinical Trial

Year of Publication:

2022

Publication:

2022

Contained In:

WHO International Clinical Trials Registry Platform - (2022) vom: 10. Jan. To Main Record - year:2022

Language:

Unbestimmt

Links:

Volltext [kostenfrei]

Keywords:

610
Medical Condition: The eligible COVID-19 patients who admit at Ramathibodi Hospitel, Ramathibodi Hospital and Ramathibodi Chakri Naruebodindra Hospital with new onset smell loss who capable to perform nasal irrigation themselves. COVID-19, Anosmia, Hyposmia, Budesonide;COVID-19, Anosmia, Hyposmia, Budesonide
Phase: Phase 3
Recruitment Status: Recruiting
Study Type: Interventional

Notes:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 14-07-2021, Last updated: 2022-01-17

PPN (Catalogue-ID):

WHO007857195